Greg Carson

Greg Carson is the current COO at ETT. Greg has also worked as Senior Director of National Accounts at Xenex Disinfection Services from January 2015 to January 2016, and as National Sales Manager at Nova Biomedical from July 2010 to January 2015.

At Xenex, Greg was responsible for implementing GPO/IDN strategy nationwide. This included pricing and marketing strategies that addressed industry needs, such as HAI Reduction Guarantee Programs, Bulk Purchasing Programs, Mercury Elimination Campaigns, HAC Campaigns, and ROI Financial Models.

At Nova Biomedical, Greg was responsible for US capital equipment sales of Blood Gas analyzers and Point of Care devices to support the care for all patients in all areas of the hospital including critical care settings. Greg led a team of 6 region managers and 36 account executives and account managers. Greg also managed the Top 10 IDN's within the United States. Their position required strong strategic selling and presentation skills to address multiple buying teams throughout the capital equipment and consumables purchasing process to include the lab, POC, Risk Management, Infectious Disease, diabetes education, reimbursement, value analysis committees, and all C level positions within the hospital.

Greg Carson has a Bachelor of Science in Human Sciences from Florida State University.

Some individuals on their team include Jay McDougall - Director of Development, David Smith - CTO, and Gregory Van Beek - Chief Investment Officer.